CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2.

Faghihi, H

Faghihi, H.

Faghihi H; Department of Pharmaceutics, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. Faghihi.h@iums.ac.ir.

Eur Rev Med Pharmacol Sci ; 24(23): 11992-11994, 2020 12.

Article in English | MEDLINE | ID: covidwho-994999

Subject(s)

Basigin/metabolism; COVID-19 Drug Treatment; Receptors, Coronavirus/metabolism; Spike Glycoprotein, Coronavirus/metabolism; Angiotensin-Converting Enzyme 2/metabolism; Antibodies, Monoclonal, Humanized/therapeutic use; Basigin/antagonists & inhibitors; Basigin/immunology; COVID-19/immunology; Cyclophilin A/immunology; Humans; Lymphopenia/immunology; SARS-CoV-2; T-Lymphocytes/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Basigin / Spike Glycoprotein, Coronavirus / Receptors, Coronavirus / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2020 Document Type: Article Affiliation country: Eurrev_202012_23985

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google